Mortality among patients with low-grade follicular lymphoma: A binational retrospective analysis.

Aino RajamäkiMika HujoReijo SundRoosa Enni Inkeri PrusilaMilla E L KuusistoHanne KuitunenEsa JantunenSantiago MercadalMarc SorigueJuan-Manuel SanchoKaisa SunelaOuti Kuittinen

Published in: Cancer (2022)

Deaths from progressive lymphoma are nearly as common as deaths from other causes in FL patients during the rituximab era. Despite the improvements in survival, there was evidence of excess mortality resulting from FL for at least 10 years after diagnosis.

Keyphrases

low grade
diffuse large b cell lymphoma
high grade
cardiovascular events
end stage renal disease
ejection fraction
newly diagnosed
multiple sclerosis
risk factors
patient reported outcomes
free survival